Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Secord is a private pharmaceutical consulting company focused on regulatory affairs, quality assurance, FDA electronic submissions, publishing, document archiving, and related compliance support services for life sciences clients. The company states it has more than 20 years of experience supporting pharmaceutical industry clients across FDA-regulated products, including prescription drugs, biologics, consumer drugs, devices, and DSHEA products. Secord has been involved in IND, NDA, BLA, ANDA/505(b)(2), and 510(k) submissions, as well as orphan drug designation applications, advisory committee preparation, and FDA meeting support. Rather than developing its own therapeutic pipeline, the firm operates as a specialized services provider helping domestic and international pharmaceutical companies manage regulatory processes and information workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Secord.